Commercial production begins at Solazyme Bunge Renewable Oils plant in Brazil
Mary Page Bailey
Solazyme, Inc. (South San Francisco, Calif.; www.solazyme.com), a renewable oil and bioproducts company, today announced that its joint venture with Bunge Global Innovation LLC (“Bunge”), a wholly-owned subsidiary of Bunge Ltd. (White Plains, N.Y.; www.bunge.com), has successfully produced its first commercially saleable products on full-scale production lines at the Solazyme Bunge Renewable Oils plant in Brazil. Both oil and encapsulated lubricant, Encapso, products have been manufactured; production is continuing and is expected to reach nameplate capacity within the next 12-18 months.
“With production underway at the Solazyme Bunge Renewable Oils plant, Solazyme is manufacturing products at three large scale facilities, including our 2,000-metric-tons-per-year (m.t./yr) integrated facility in Peoria, the 20,000-m.t./yr Iowa facilities in Clinton/Galva and the 100,000-m.t./yr facility in Brazil,” said Jonathan Wolfson, CEO Solazyme. “Continued progress at the recently completed adjoining co-gen facility has resulted in more reliable power and steam, enabling startup of commercial operations and production of our first commercially saleable product. We are truly excited to have begun manufacturing operations at our joint venture’s flagship facility in Brazil.”